211 related articles for article (PubMed ID: 24909066)
1. Editorial comment from Dr Urakami to impact of obesity on the predictive accuracy of prostate-specific antigen density and prostate-specific antigen in native Korean men undergoing prostate biopsy.
Urakami S
Int J Urol; 2014 Oct; 21(10):990-1. PubMed ID: 24909066
[No Abstract] [Full Text] [Related]
2. Editorial comment from Dr Simonato and Dr Romagnoli to impact of obesity on the predictive accuracy of prostate-specific antigen density and prostate-specific antigen in native Korean men undergoing prostate biopsy.
Simonato A; Romagnoli A
Int J Urol; 2014 Oct; 21(10):991. PubMed ID: 24931339
[No Abstract] [Full Text] [Related]
3. Impact of obesity on the predictive accuracy of prostate-specific antigen density and prostate-specific antigen in native Korean men undergoing prostate biopsy.
Kim JH; Doo SW; Yang WJ; Lee KW; Lee CH; Song YS; Jeon YS; Kim ME; Kwon SS
Int J Urol; 2014 Oct; 21(10):987-90. PubMed ID: 24825391
[TBL] [Abstract][Full Text] [Related]
4. Re: The Impact of Obesity on the Predictive Accuracy of PSA in Men Undergoing Prostate Biopsy.
Kaplan SA
J Urol; 2015 Aug; 194(2):394-5. PubMed ID: 26195366
[No Abstract] [Full Text] [Related]
5. Editorial comment to association of prostate-specific antigen doubling time and cancer in men undergoing repeat prostate biopsy.
Shimbo M
Int J Urol; 2012 Aug; 19(8):747-8. PubMed ID: 22651131
[No Abstract] [Full Text] [Related]
6. Editorial comment.
Schilling D; Stenzl A
J Urol; 2010 Feb; 183(2):527-8; discussion 528. PubMed ID: 20006885
[No Abstract] [Full Text] [Related]
7. Does obesity affect the accuracy of prostate-specific antigen (PSA) for predicting prostate cancer among men undergoing prostate biopsy.
Oh JJ; Jeong SJ; Lee BK; Jeong CW; Byun SS; Hong SK; Lee SE
BJU Int; 2013 Aug; 112(4):E265-71. PubMed ID: 23432960
[TBL] [Abstract][Full Text] [Related]
8. Editorial comment on: decision-making about PSA testing and prostate biopsies: a qualitative study embedded in a primary care randomised trial.
Finney Rutten LJ
Eur Urol; 2008 Jun; 53(6):1193. PubMed ID: 17709172
[No Abstract] [Full Text] [Related]
9. Editorial Comment to Importance of prostate volume in the stratification of patients with intermediate-risk prostate cancer.
Yashi M
Int J Urol; 2015 Jun; 22(6):561-2. PubMed ID: 25799888
[No Abstract] [Full Text] [Related]
10. The interplay between obesity and the accuracy of prostate-specific antigen (PSA) for predicting prostate cancer.
Granieri MA; Freedland SJ
BJU Int; 2013 Aug; 112(4):E272. PubMed ID: 23879911
[No Abstract] [Full Text] [Related]
11. Does Obesity Modify the Ability of Prebiopsy Prostate Specific Antigen to Detect Prostate Cancer on Repeat Biopsy? Results from the REDUCE Study.
Vidal AC; Howard LE; Moreira DM; Castro-Santamaria R; Andriole GL; Freedland SJ
J Urol; 2015 Jul; 194(1):52-7. PubMed ID: 25661298
[TBL] [Abstract][Full Text] [Related]
12. Editorial comment. Correlation between serum prostate-specific antigen and cancer volume in prostate glands of different sizes.
Autorino R; Perdonà S; Di Lorenzo G
Urology; 2010 Nov; 76(5):1076; author reply 1076-7. PubMed ID: 21056255
[No Abstract] [Full Text] [Related]
13. Editorial comment.
Ukimura O
J Urol; 2014 Dec; 192(6):1648; discussion 1649. PubMed ID: 25194546
[No Abstract] [Full Text] [Related]
14. Editorial comment.
Phillips J
J Urol; 2014 Dec; 192(6):1649; discussion 1649. PubMed ID: 25194544
[No Abstract] [Full Text] [Related]
15. Detection rate of prostate cancer on biopsy according to serum prostate-specific antigen in Korean men: a multicenter study.
Yang WJ; Lee DH; Chung BH; Cho JS; Choi YD; Kim SJ; Cho IR; Kim HS; Kim CI; Hong SJ;
Urology; 2006 Feb; 67(2):333-6. PubMed ID: 16461083
[TBL] [Abstract][Full Text] [Related]
16. Editorial comment on: prostate-specific antigen kinetics in clinical decision-making during active surveillance for early prostate cancer--a review.
Rittmaster R
Eur Urol; 2008 Sep; 54(3):514-5. PubMed ID: 18585846
[No Abstract] [Full Text] [Related]
17. Editorial comment on: Post-treatment prostate biopsies in the era of three-dimensional conformal radiotherapy: what can they teach us?
Stanislaus P; Seitz M
Eur Urol; 2009 Apr; 55(4):909-10. PubMed ID: 18485577
[No Abstract] [Full Text] [Related]
18. Editorial comment: Critical role of prostate biopsy mortality in the number of years of life gained and lost within a prostate cancer screening programme.
Albertsen PC
BJU Int; 2012 Dec; 110(11):1653. PubMed ID: 22984891
[No Abstract] [Full Text] [Related]
19. Editorial Comment.
Benson MC
Urology; 2016 Apr; 90():147. PubMed ID: 27036684
[No Abstract] [Full Text] [Related]
20. Editorial comment. Body mass index adjusted prostate-specific antigen and its application for prostate cancer screening.
Bañez LL
Urology; 2010 Nov; 76(5):e4. PubMed ID: 21056250
[No Abstract] [Full Text] [Related]
[Next] [New Search]
